Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growth
GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the "First Half of 2024").
First Half of 2024 Financial Highlights
Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.
Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.
Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.
Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.
Ms. Haimei Wu, Founder and CEO of Baird Medical, commented, "Our preliminary results for the first half of 2024 reflect ...
